Benzylamine derivatives
US9670157B2 · kind B2 · utility
13Cited by
3References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2014 |
| Grant date | Jun 6, 2017 |
| Priority date | — |
| Expiry date | Jan 8, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.